Return to search

MUCI interacts with Wnt-effector B-catenin in human oesophageal squamous cell carcinoma cell lines

ABSTRACT

MUC1, a mucin-like transmembrane glycoprotein, is highly overexpressed and aberrantly
localized in several invasive carcinomas. MUC1 is proposed to play numerous roles in
the transformed behaviour of cells in which it is expressed. A number of these roles are
facilitated by the interaction of MUC1 with β-catenin, a protein that is central to both
cellular adhesion as well as Wnt-responsive gene transcription. The aim of this study was
to investigate MUC1 expression, localization, and interaction with β-catenin, as a means
of providing insight into the behaviour of human oesophageal squamous cell carcinoma.
This cancer-type is exceptionally aggressive and is a major cause of cancer-related
morbidity and mortality in South Africa. MUC1 is expressed and aberrantly localized in
oesophageal squamous cell carcinoma cell lines, as demonstrated by RT-PCR, western
blotting and indirect immunofluorescence. Moreover, evidence from coimmunoprecipitation
assays shows that the MUC1 cytoplasmic tail and β-catenin form a
complex both at the cell membrane and importantly, within the nucleus of these cell lines.
This is the first demonstration of such a complex in the nucleus of a carcinoma derived
from stratified, as opposed to simple, epithelia. Data presented here further indicates that
activation of the epidermal growth factor receptor results in modulation of the association
between MUC1 and β-catenin at the cell membrane. MUC1 membrane-localization, and
interaction with β-catenin, may modulate cellular adhesion through steric interference of
cell surface adhesion molecules as well as through sequestration of β-catenin away from
adherens junctions. On the other hand, MUC1 association with β-catenin may enhance β-
catenin signalling either through the stabilization of β-catenin, or as an essential
functional component of the β-catenin/LEF/TCF transcription factor complex. Furthermore, results presented in this study identify oesophageal squamous cell
carcinoma as a prime candidate for MUC1-specific immunotherapy. This finding is of
substantial importance considering the ineffectual nature of existing therapies used in the
treatment of oesophageal carcinoma.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:wits/oai:wiredspace.wits.ac.za:10539/4731
Date03 April 2008
CreatorsMetcalfe, Ciara
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
TypeThesis
Format2154471 bytes, application/pdf, application/pdf

Page generated in 0.0021 seconds